Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany. more
Time Frame | BAYRY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.63% | -2.12% | 0.77% |
1-Month Return | -18.25% | -2.54% | 2.65% |
3-Month Return | -34.27% | -6.28% | 12.3% |
6-Month Return | -31.98% | -1.36% | 13.48% |
1-Year Return | -39.75% | 9.29% | 33.47% |
3-Year Return | -58.09% | 10.05% | 32.22% |
5-Year Return | -72.45% | 43.69% | 92.85% |
10-Year Return | -85.4% | 103.1% | 194.31% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 43.55B | 41.40B | 44.08B | 50.74B | 47.64B | [{"date":"2019-12-31","value":85.82,"profit":true},{"date":"2020-12-31","value":81.59,"profit":true},{"date":"2021-12-31","value":86.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.89,"profit":true}] |
Cost of Revenue | 17.47B | 19.14B | 16.82B | 19.87B | 19.75B | [{"date":"2019-12-31","value":87.9,"profit":true},{"date":"2020-12-31","value":96.31,"profit":true},{"date":"2021-12-31","value":84.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.39,"profit":true}] |
Gross Profit | 26.08B | 22.26B | 27.27B | 30.87B | 27.89B | [{"date":"2019-12-31","value":84.48,"profit":true},{"date":"2020-12-31","value":72.12,"profit":true},{"date":"2021-12-31","value":88.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.35,"profit":true}] |
Gross Margin | 59.89% | 53.77% | 61.85% | 60.84% | 58.54% | [{"date":"2019-12-31","value":96.82,"profit":true},{"date":"2020-12-31","value":86.94,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.36,"profit":true},{"date":"2023-12-31","value":94.65,"profit":true}] |
Operating Expenses | 21.55B | 22.98B | 20.36B | 23.54B | 20.34B | [{"date":"2019-12-31","value":91.55,"profit":true},{"date":"2020-12-31","value":97.62,"profit":true},{"date":"2021-12-31","value":86.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86.44,"profit":true}] |
Operating Income | 5.04B | (2.94B) | 6.97B | 6.26B | 7.55B | [{"date":"2019-12-31","value":66.79,"profit":true},{"date":"2020-12-31","value":-38.94,"profit":false},{"date":"2021-12-31","value":92.42,"profit":true},{"date":"2022-12-31","value":83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (3.66B) | (6.58B) | (5.68B) | (5.57B) | (10.78B) | [{"date":"2019-12-31","value":-366000000000,"profit":false},{"date":"2020-12-31","value":-658300000000,"profit":false},{"date":"2021-12-31","value":-568300000000,"profit":false},{"date":"2022-12-31","value":-556600000000,"profit":false},{"date":"2023-12-31","value":-1077900000000,"profit":false}] |
Pre-Tax Income | 2.88B | (17.25B) | 2.05B | 4.67B | (1.62B) | [{"date":"2019-12-31","value":61.67,"profit":true},{"date":"2020-12-31","value":-369.38,"profit":false},{"date":"2021-12-31","value":43.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-34.71,"profit":false}] |
Income Taxes | 450.00M | (1.69B) | 1.02B | 504.00M | 1.32B | [{"date":"2019-12-31","value":34.07,"profit":true},{"date":"2020-12-31","value":-127.86,"profit":false},{"date":"2021-12-31","value":77.52,"profit":true},{"date":"2022-12-31","value":38.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 2.43B | (15.56B) | 1.02B | 4.17B | (2.94B) | [{"date":"2019-12-31","value":58.33,"profit":true},{"date":"2020-12-31","value":-373.52,"profit":false},{"date":"2021-12-31","value":24.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.62,"profit":false}] |
Income From Continuous Operations | 2.43B | (15.56B) | 1.02B | 4.17B | (2.94B) | [{"date":"2019-12-31","value":58.33,"profit":true},{"date":"2020-12-31","value":-373.52,"profit":false},{"date":"2021-12-31","value":24.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.62,"profit":false}] |
Income From Discontinued Operations | 1.70B | 5.07B | - | - | - | [{"date":"2019-12-31","value":33.5,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 2.43B | (15.56B) | 1.00B | 4.15B | (2.94B) | [{"date":"2019-12-31","value":58.55,"profit":true},{"date":"2020-12-31","value":-374.96,"profit":false},{"date":"2021-12-31","value":24.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.87,"profit":false}] |
EPS (Diluted) | 1.85 | 1.80 | 2.84 | 2.13 | 1.72 | [{"date":"2019-12-31","value":65.1,"profit":true},{"date":"2020-12-31","value":63.34,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.95,"profit":true},{"date":"2023-12-31","value":60.52,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
BAYRY | |
---|---|
Cash Ratio | 0.25 |
Current Ratio | 1.32 |
Quick Ratio | 0.81 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BAYRY | |
---|---|
ROA (LTM) | 5.11% |
ROE (LTM) | -2.73% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BAYRY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.71 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.29 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BAYRY | |
---|---|
Trailing PE | NM |
Forward PE | 1.50 |
P/S (TTM) | 0.44 |
P/B | 0.64 |
Price/FCF | 14 |
EV/R | 1.11 |
EV/Ebitda | 5.55 |
PEG | 37.01 |
Bayer AG PK (BAYRY) share price today is $5.26
Yes, Indians can buy shares of Bayer AG PK (BAYRY) on Vested. To buy Bayer AG PK from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BAYRY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bayer AG PK (BAYRY) via the Vested app. You can start investing in Bayer AG PK (BAYRY) with a minimum investment of $1.
You can invest in shares of Bayer AG PK (BAYRY) via Vested in three simple steps:
The 52-week high price of Bayer AG PK (BAYRY) is $9.68. The 52-week low price of Bayer AG PK (BAYRY) is $4.94.
The price-to-earnings (P/E) ratio of Bayer AG PK (BAYRY) is
The price-to-book (P/B) ratio of Bayer AG PK (BAYRY) is 0.64
The dividend yield of Bayer AG PK (BAYRY) is 0.55%
The market capitalization of Bayer AG PK (BAYRY) is $21.00B
The stock symbol (or ticker) of Bayer AG PK is BAYRY